Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
RNTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $68.04M
- EPS (TTM)
- -$1.68
- Dividend yield
- None
- 52-week range
- 0.694 – 2.18
- Day range
- 0.7805 – 0.8169
- Volume / Avg
- 446.97K / 427.95K
- Beta
- —
- Shares outstanding
- 86.27M
52-week range
RNTX stock today
Rein Therapeutics (RNTX) closed at $0.7887 on Oct 7, down 4.40% (-$0.0363), versus the S&P 500's 0.22% decline. At this level, RNTX sits near the bottom of its 52-week range of $0.694 to $2.18: 63.8% below the high, set on Nov 3, 2025 and 13.6% above the low. RNTX is down 32.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 45.2%.
Rein Therapeutics has posted a net loss over the last twelve months (EPS of -$1.68), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Rein Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2017
Rein Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| FBIOFortress Biotech Inc. | 2.04 | -0.49% | $68.04M | vs RNTX |
| SPROSpero Therapeutics Inc. | 1.17 | -1.68% | $68.13M | vs RNTX |
| NMADNomad Power Solutions Inc. | 4.25 | -2.19% | $68.43M | vs RNTX |
| XBITXBiotech Inc. | 2.19 | +1.39% | $66.77M | vs RNTX |
| HYFTMindWalk Holdings Corp. | 1.50 | -3.23% | $70.67M | vs RNTX |
| CINGCingulate Inc. | 4.87 | -0.41% | $70.82M | vs RNTX |
| VRCAVerrica Pharmaceuticals Inc. | 4.14 | -1.66% | $71.12M | vs RNTX |
| IBIOiBio Inc. | 1.01 | -3.81% | $64.95M | vs RNTX |
Indexes, lists and sector
Rein Therapeutics stock FAQ
What is Rein Therapeutics's stock price today?
RNTX last traded at $0.7887 as of Oct 7, 4:00 PM EDT, down 4.40% on the day. Prices are delayed at least 15 minutes.
Does Rein Therapeutics pay a dividend?
No. Rein Therapeutics does not currently pay a regular cash dividend.
Has RNTX ever split its stock?
Yes. The most recent RNTX stock split was a 1-for-20 split on Nov 11, 2022.
What is the RNTX 52-week high?
The 52-week high for RNTX is $2.18 and the 52-week low is $0.694. The stock is currently 63.8% below its high.